InnovAge (OTCMKTS:INNV) Stock Price Down 4.6% – Should You Sell?

InnovAge Holding Corp. (OTCMKTS:INNVGet Free Report) traded down 4.6% during trading on Thursday . The company traded as low as $4.55 and last traded at $4.58. 28,264 shares traded hands during trading, a decline of 26% from the average session volume of 38,268 shares. The stock had previously closed at $4.80.

InnovAge Price Performance

The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.25. The firm has a market cap of $620.38 million, a PE ratio of -38.17 and a beta of 0.31. The stock has a 50 day simple moving average of $5.42 and a 200-day simple moving average of $5.53.

InnovAge (OTCMKTS:INNVGet Free Report) last posted its quarterly earnings data on Tuesday, September 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.01. InnovAge had a negative return on equity of 13.04% and a negative net margin of 6.17%. The business had revenue of $199.40 million during the quarter, compared to analyst estimates of $190.19 million. Equities analysts anticipate that InnovAge Holding Corp. will post -0.25 earnings per share for the current fiscal year.

InnovAge Company Profile

(Get Free Report)

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.

Featured Articles

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.